Clearmind Medicine Inc. Noncash Effect Of Exchange Differences Supplier Finance Arrangements
Clearmind Medicine Inc. (CMND) reported Noncash Effect Of Exchange Differences Supplier Finance Arrangements of $181.78 thousand for the 12-month period ending 2024-10-31, per its 20-F filed 2026-01-20.
Financial Statements › Notes
ifrs-full:NoncashEffectOfExchangeDifferencesSupplierFinanceArrangements · last filed 2026-01-20
- Clearmind Medicine Inc. noncash effect of exchange differences supplier finance arrangements for the quarter ending 2024-10-31 was $0.00.
- Clearmind Medicine Inc. noncash effect of exchange differences supplier finance arrangements for the quarter ending 2024-07-31 was $73.95K.
- Clearmind Medicine Inc. noncash effect of exchange differences supplier finance arrangements for the quarter ending 2024-04-30 was $7.01K.
- Clearmind Medicine Inc. noncash effect of exchange differences supplier finance arrangements for the quarter ending 2024-01-31 was $100.82K.
| Period end | Noncash Effect Of Exchange Differences Supplier Finance Arrangements 3 month | Noncash Effect Of Exchange Differences Supplier Finance Arrangements 6 month | Noncash Effect Of Exchange Differences Supplier Finance Arrangements 9 month | Noncash Effect Of Exchange Differences Supplier Finance Arrangements 12 month |
|---|---|---|---|---|
| 2024-10-31 | $0.00 derived: 20-F 12 month − 6-K 9 month · filed 2026-01-20 | $73.95K derived: sum of 2 quarters · filed 2026-01-20 | $80.96K derived: sum of 3 quarters · filed 2026-01-20 | $181.78K 20-F · filed 2026-01-20 |
| 2024-07-31 | $73.95K derived: 6-K 9 month − 6-K 6 month · filed 2025-09-11 | $80.96K derived: sum of 2 quarters · filed 2025-09-11 | $181.78K 6-K · filed 2025-09-11 | |
| 2024-04-30 | $7.01K derived: 6-K 6 month − 6-K 3 month · filed 2025-06-12 | $107.83K 6-K · filed 2025-06-12 | ||
| 2024-01-31 | $100.82K 6-K · filed 2025-03-13 | |||
| 2022-10-31 | $92.73K 20-F · filed 2025-01-22 |